Ακαδημαϊκα Προσοντα
| Qualification | Year | Awarding Institution | Department | Thesis title (Optional Entry) |
| Medical Doctor | 1984 | University of Antwerpen | Faculty of Medicine | |
| Master degree in occupational Medicine | 1991 | University of Antwerpen | Faculty of Medicine | |
| PhD in Epidemiology and Social Medicine | 1994 | University of Antwerpen | Faculty of Medicine | Epidemiology and prevention of hepatitis B |
Ιστορικο Εργοδοτησης
| Period of employment | Employer | Location | Position | |
| From | To | |||
| 1984 | 1985 | Vesalius Hospital | Brasschaat, Belgium | Assistant internal medicine |
| 1985 | 1999 | University of Antwerpen | Wilrijk, Antwerpen, Belgium | Research assistant |
| 2000 | present | University of Antwerpen | Wilrijk, Antwerpen, Belgium | professor |
Δημοσιευσεις
| Ref. Number | Year | Title | Other authors | Journal and Publisher / Conference | Vol. | Pages |
| PMID: 34590138 | 2021 | Hepatitis B vaccines | Pattyn J, Hendrickx G, Vorsters A | J Infect Dis | 224 | 343-351 |
| PMID: 33676783 | 2020 | Improving Vaccine-Induced Immunity: Can Baseline Predict Outcome? | Tsang JS, Dobaño C, Moncunill G, Marchant A, Othman RB, Sadarangani M, Koff WC, Kollmann TR. | Trends Immunol. | 41 | 457-465 |
| PMID: 31482728 | 2019 | Poliopolis: pushing boundaries of scientific innovations for disease eradication. | Coster I, Bandyopadhyay AS, Suykens L, Rudelsheim P, Neels P, Oberste MS, Weldon WC, Clemens R, Revets H. | Future Microbiol. | 14 | 1321-1330 |
| PMID: 31174831 | 2019 | The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 study | De Coster I, Bandyopadhyay AS, Revets H, Withanage K, De Smedt P, Suykens L, Oberste MS, Weldon WC, Costa-Clemens SA, Clemens R, Modlin J, Weiner AJ, Macadam AJ, Andino R, Kew OM, Konopka-Anstadt JL, Burns CC, Konz J, Wahid R, Gast C. | Lancet | 394 | 148-158 |
| PMID: 31087382 | 2019 | Persistence of HBsAg-specific antibodies and immune memory two to three decades after hepatitis B vaccination in adults. | Dionne M, Leroux-Roels G, Van Der Meeren O, Di Paolo E, Salaun B, Surya Kiran P, Folschweiller N. | J Viral Hepat | 26 | 1066-1075 |
| PMID: 26802140 | 2016 | Long-term Protection After Hepatitis B Vaccine. | J Infect Dis | 214 | 1-3 | |
| PMID: 21653306 | 2011 | Hepatitis B and the need for a booster dose. | Leuridan E | Clin Infect Dis | 53 | 68-75 |
| PMID: 20483946 | 2010 | Early waning of maternal measles antibodies in era of measles elimination: longitudinal study. | Leuridan E, Hens N, Hutse V, Ieven M, Aerts M | BMJ | 340 | 1-7 |
| PMID: 18776823 | 2008 | Benefits of early hepatitis B immunization programs for newborns and infants. | Van Herck K | Ped Infect Dis J | 27 | 1-9 |
| PMID: 9112852 | 1997 | Integration of hepatitis B vaccination into national immunisation programmes. | Kane M, Meheus A. | BMJ | 314 | 1033-1036 |
| PMID: 7897376 | 1994 | Single dose inactivated hepatitis A vaccine: rationale and clinical assessment of the safety and immunogenicity. | Matheï C, Thoelen S, Meheus A, Safary A, André FE | J Med Virol | 44 | 435-441 |
Εκθεσεις
Ερευνητικα Projects
| Date | Title | Funded by | Project Role* |
| 2021-2025 | Cervical cancer screening based on self sampling of first void urine to reach non-responders to screening programs: ScreenUrSelf | Flemish Scientific Fund | Principle Investigator |
| 2021-2026 | Methusalem funding for VAX-IDEA: prevention, control and management of infectious diseases in a ‘one health’ policy | Special Research Fund – Flemish Government & University of Antwerp | Coordinator |
| 2021-2024 | Optimal timing for vaccination in pregnancy: a multidimentional mechanistic approach for immune response measurement in pregnant women | Flemish Scientific Fund | Promotor |
| 2018-2023 | EBOVAC3: a phase 2 Ebola vaccine trial in DRCongo | EU-IMI | Promotor |
| 2021-2021 | Confidence in vaccines | King Baudouin Foundation | Promotor |
| 2020-2021 | Assessment of SARS-CoV-2 infections in pregnant women and their neonates | Special Research Fund – Flemish Government & University of Antwerp | Promotor |
Ακαδημαϊκες Συμβουλευτικες Υπηρεσιες/Συμμετοχη σε Συμβουλια/Επιτροπές
| Period | Organization | Title of Position or Service |
| 2010-2016 | Unicef Belgium | Member of the board |
| 2018-2022 | University Hospital Antwerpen | Member of the board |
| 2000-present | Flemish Vaccination Platform | Member |
| 1998-present | National ImmunizationTechnical Advisory Group | Member |
| 2008-present | Ropyal Academy of Medicine | Member |
| 1998-present | Vocatio Foundation | Member and chair of the jury (2022-present) |
| 2005-2015 | European Techincal Advisory Group of Experts on immunization, WHO EURO | Chair |
| 1998-present | WHO collaborating centre for the control and prevention of infectious diseases | Director |
Βραβευσεις/Διεθνεις Διακρισεις
| Date | Title | Awarded by: |
| 2021 | PRoF award of Research 2021 | https://www.prof-projects.com/prof-award-winners.html |
| 2019 | Balmis distinction Award | Almeira University, Spain |
| 2019 | AHA Antwerp Innovation Award | Province of Antwerp/University of Antwerp |
| 2017 | Paul Harris Fellowship Award | Rotary Foundation of Rotary International |
| 2017 | ACRP outstanding leadership award | Ass. Of Clinical Research Professionals |
| 2014 | Bill Marshall Award | ESPID (Eur. Society of Ped. Infectious Diseases) |
| 2000 | Jean Van Beneden award for Social Medicine | University of Liège, Belgium |
| 1998 | University of Antwerp, Research Award | University of Antwerp |